These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37038667)

  • 1. Assessment of thyroid function in patients with rheumatoid arthritis in Kunming, China: A case-control study.
    He F; Li F; Zuo D; Ma S; Chen Y; Ying J; Zhu L
    Curr Med Imaging; 2023 Apr; ():. PubMed ID: 37038667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothyroidism and autoimmune thyroid disorders in rheumatoıd arthritis: relationship wıth disease activity.
    Karakiliç GD; Borman P; Kocaoğlu S; Büyük F; Bakirci EŞ
    Rom J Intern Med; 2024 Jun; 62(2):160-167. PubMed ID: 38281120
    [No Abstract]   [Full Text] [Related]  

  • 3. The association of immunoglobulin A, immunoglobulin G and anti-cyclic citrullinated peptide antibodies with disease activity in seronegative rheumatoid arthritis patients.
    Karimifar M; Moussavi H; Babaei M; Akbari M
    J Res Med Sci; 2014 Sep; 19(9):823-6. PubMed ID: 25535495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique correlation between mutated citrullinated vimentine IgG autoantibodies and markers of systemic inflammation in rheumatoid arthritis patients.
    Zahran WE; Mahmoud MI; Shalaby KA; Abbas MH
    Indian J Clin Biochem; 2013 Jul; 28(3):272-6. PubMed ID: 24426223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value.
    Atzeni F; Doria A; Ghirardello A; Turiel M; Batticciotto A; Carrabba M; Sarzi-Puttini P
    Autoimmunity; 2008 Feb; 41(1):111-5. PubMed ID: 18176873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joints-C-reactive protein (DAS28-CRP): An observational cohort study.
    Emamifar A; Hangaard J; Jensen Hansen IM
    Medicine (Baltimore); 2017 Oct; 96(43):e8357. PubMed ID: 29069018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of hypothyroidism in rheumatoid arthritis and its correlation with disease activity.
    Joshi P; Agarwal A; Vyas S; Kumar R
    Trop Doct; 2017 Jan; 47(1):6-10. PubMed ID: 26792597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic differences in the prognostic utility of rheumatoid factor isotypes and anticyclic citrullinated peptides in rheumatoid arthritis patients: a cross-sectional study.
    Gomez EL; Gun SC; Somanath SD; Chinna K; Radhakrishnan AK
    Mod Rheumatol; 2013 Jul; 23(4):716-21. PubMed ID: 22854883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.
    Rantapää-Dahlqvist S; de Jong BA; Berglin E; Hallmans G; Wadell G; Stenlund H; Sundin U; van Venrooij WJ
    Arthritis Rheum; 2003 Oct; 48(10):2741-9. PubMed ID: 14558078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
    Agrawal S; Misra R; Aggarwal A
    Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Clinical Use of Anti-Thyroid Antibodies in RA Patients: A Prospective Case-Control Study.
    Haridas V; Haridas K
    J Assoc Physicians India; 2018 May; 66(5):14-6. PubMed ID: 30477056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series.
    Zhao T; Shen J; Zhu Y; Tian X; Wen G; Wei Y; Xu B; Fu C; Xie Z; Xi Y; Li Z; Peng J; Wu Y; Tang X; Wan C; Pan L; Li Z; Qin D
    Front Public Health; 2022; 10():875558. PubMed ID: 35548080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.
    da Mota LM; Dos Santos Neto LL; de Carvalho JF; Pereira IA; Burlingame R; Ménard HA; Laurindo IM
    Rheumatol Int; 2012 Dec; 32(12):3807-12. PubMed ID: 22187055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between rheumatoid factor isotypes and IgG anti-cyclic citrullinated peptide antibodies.
    Jaskowski TD; Hill HR; Russo KL; Lakos G; Szekanecz Z; Teodorescu M
    J Rheumatol; 2010 Aug; 37(8):1582-8. PubMed ID: 20516016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes with HLA-DRB1 shared epitope alleles in Egyptian rheumatoid arthritis patients.
    Raslan HM; Attia HR; Hamed Ibrahim M; Mahmoud Hassan E; Salama II; Ismail S; Abdelmotaleb E; El Menyawi MM; Amr KS
    Int J Rheum Dis; 2020 May; 23(5):647-653. PubMed ID: 32167241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
    Liu Y; Wang YF; Wang KL; Lv FF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.